Development and Optimization of Olaparib-Encapsulated Silica Nanocarriers for Enhanced Therapeutic Efficacy in Ovarian Cancer: Cytotoxicity Profiling in HaCaT and SK-OV-3 Cell Models

Journal of Pharmaceutical Innovation 2026

View at publisher

Authors: Ankita Gupta, Swatantra K.S. Kushwaha, Amit Kumar Mishra

DOI: 10.1007/s12247-025-10324-w

Cited by: 0

References: 54

Fields of Study & Subjects

Nanoparticle-Based Drug Delivery PARP inhibition in cancer therapy Cancer Treatment and Pharmacology

References 54